CEBPB is associated with the development of various tumors, including osteosarcoma, gastric cancer, HCC, glioblastoma, and human acute myeloid leukemia (Lu et al., 2019; Jinesh et al., 2020). This evidence concerns the gene CEBPB and osteosarcoma.